Bank Of New York Mellon Corp Magenta Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $5,777 - $25,517	16,049 New	16,049 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $67,097 - $213,052	-69,173 Reduced 81.13%	16,084 $19,000
Q1 2022 May 11, 2022	SELL	$2.55 - $5.23 $153 - $313	-60 Reduced 0.07%	85,257 $247,000
Q4 2021 Feb 11, 2022	BUY	$4.43 - $8.33 $7,203 - $13,544	1,626 Added 1.94%	85,317 $378,000
Q3 2021 Nov 12, 2021	BUY	$6.07 - $9.89 $25,943 - $42,269	4,274 Added 5.38%	83,691 $609,000
Q2 2021 Aug 11, 2021	BUY	$9.76 - $14.15 $126,196 - $182,959	12,930 Added 19.45%	79,417 $776,000
Q1 2021 May 13, 2021	SELL	$7.66 - $13.38 $9,337 - $16,310	-1,219 Reduced 1.8%	66,487 $787,000
Q4 2020 Feb 09, 2021	BUY	$6.1 - $7.94 $13,426 - $17,475	2,201 Added 3.36%	67,706 $530,000
Q3 2020 Nov 12, 2020	SELL	$6.52 - $8.94 $7,178 - $9,842	-1,101 Reduced 1.65%	65,505 $445,000
Q2 2020 Aug 12, 2020	BUY	$6.18 - $10.76 $24,102 - $41,964	3,900 Added 6.22%	66,606 $500,000
Q1 2020 May 06, 2020	SELL	$6.03 - $15.24 $976 - $2,468	-162 Reduced 0.26%	62,706 $393,000
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $27,073 - $47,282	2,985 Added 4.98%	62,868 $953,000
Q3 2019 Nov 07, 2019	BUY	$9.63 - $14.0 $67,130 - $97,594	6,971 Added 13.17%	59,883 $614,000
Q2 2019 Aug 12, 2019	BUY	$13.4 - $17.67 $133,732 - $176,346	9,980 Added 23.25%	52,912 $781,000
Q1 2019 May 14, 2019	BUY	$5.7 - $19.7 $154,914 - $535,406	27,178 Added 172.51%	42,932 $707,000
Q4 2018 Feb 11, 2019	BUY	$5.57 - $11.65 $87,749 - $183,534	15,754 New	15,754 $90,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.